Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Careful management of steroid use is crucial in pregnant women with bullous pemphigoid to avoid complications like Cushing syndrome.

Cyclosporine may cause hair loss, so patients need monitoring.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Myoblast transplantation shows promise for treating various muscle and heart conditions.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Lichen planopilaris is a chronic, scarring hair loss condition with no definitive cure, requiring accurate diagnosis and treatment to manage symptoms.

Some dermatological medications can impair male fertility, so consult a doctor before trying to conceive.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Effective treatments for severe alopecia areata are still lacking.

About 8% of people with systemic lupus erythematosus have chronic scarring alopecia, with certain symptoms and positive antibodies increasing the risk, while immunosuppressants may lower it.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

Psychosis can be an early sign of neuropsychiatric lupus, treatable with tailored medication.

Cyclosporine A was found to increase hair growth in mouse whisker follicles.

The NUDT15 gene variant causes severe side effects from azathioprine in some Indian patients.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

A woman was allergic to quinine in her anti-hair loss lotion.

Cyclosporine A promotes hair growth and prolongs the active growth phase in human hair follicles, but may work differently than in rodents.

Some herbal treatments are effective for skin disorders, but more research and regulation are needed.

Customized medications made through compounding can be beneficial for various skin conditions but require careful regulation and collaboration between doctors and pharmacists.

A patient experienced long-lasting hair loss after using acitretin for psoriasis.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Latanoprost can make eyelashes longer, thicker, and darker.

Cyclosporine A may help treat hair loss by blocking a protein that inhibits hair growth.